Joel Jager, MD
Family Medicine · Summerville, GANPI 1417976671
Payments from drug & device makers
Across 45 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$211
- Amgen$131
- Dexcom, Inc.$60
- Paratek Pharmaceuticals, Inc.$47
- Biohaven Pharmaceuticals, Inc.$41
- Pfizer$35
- plus $137 from 9 others
What the payments were for
- Food & beverage$661100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $211 |
| Amgen | 8 | $131 |
| Dexcom, Inc. | 3 | $60 |
| Paratek Pharmaceuticals, Inc. | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 1 | $41 |
| Pfizer | 2 | $35 |
| Abbott | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| GSK | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
How this compares
$661 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $2,405 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,677 |
| Doxycycline Monohydrate | 80 | $1,124 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 47 | $779 |
| Prednisone | 346 | $774 |
| Cefdinir | 58 | $717 |
| Levofloxacin | 51 | $708 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 66 | $687 |
| Ventolin HfaAlbuterol Sulfate | 13 | $675 |
| Azithromycin | 95 | $651 |
| ValacyclovirValacyclovir Hcl | 18 | $582 |
| Dexamethasone | 72 | $561 |
| Pregabalin | 22 | $557 |
| Sucralfate | 13 | $544 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 79 | $507 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Summerville
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.